Background Sarcopenia is an ever-increasingly recognized entity in aging or chronically-ill
individuals. A recent surge of researches came out on sarcopenia in rheumatoid arthritis …

Objective To evaluate the presence of sarcopenia in patients with rheumatoid arthritis (RA).
Method This cross‐sectional study included 100 patients with RA and 100 gender‐matched …

Sarcopenia was recently identified as an entity in the ICD-10 classification of October 2016.
According to the recommendation of the European Working Group on Sarcopenia in Older …

The prevalence of sarcopenia in rheumatic diseases has been evaluated in single diseases
using various diagnostic approaches, generating conflicting data on the pathogenetic …

To examine the prevalence of sarcopenia and its association with antirheumatic drugs in
adults with rheumatoid arthritis (RA). This review was registered on PROSPERO and …

Evaluate the prevalence of sarcopenia on patients with rheumatoid arthritis (RA), the
influence of sarcopenia on disease activity and factors associated with sarcopenia. One …

Objectives: Sarcopenia is characterized by loss of muscle strength and mass, leading to falls
and adverse health outcomes. Our aim was to determine the prevalence of sarcopenia in …

Background Sarcopenia, a relatively new syndrome referring to the age-related decline of
muscle strength and degenerative loss of skeletal muscle mass and function, often resulting …

Objective In rheumatoid arthritis (RA), chronic inflammation can enhance the development of
sarcopenia with a depletion of muscle mass, strength and performance. Currently, a …

Introduction Patients with rheumatoid arthritis (RA) are at higher risk of sarcopenia because
of joint dysfunction and chronic inflammation. The present study aimed to investigate the …